CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Roberts Eric W CHIEF BUSINESS OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2026-10-01 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-10-01 | Glicklich Alan Director | Grant or award · Director Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-10-01 | Zaytsev Evgeny Director | Grant or award · Director Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-10-01 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-10-01 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2026-09-24 | Stauderman Kenneth A. Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2026-09-24 | Hebbar Sudarshan Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2026-09-24 | Bardin Stephen Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2026-09-24 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +360,000 | 360,000 | ||
| 2026-08-19 | ALAFI CAPITAL CO LLC 10% owner | Grant or award · Series A Warrants | +3,529,192 | 3,529,192 | ||
| 2026-08-19 | ALAFI CAPITAL CO LLC 10% owner | Grant or award · Series B Warrants | +3,529,192 | 3,529,192 | ||
| 2026-08-19 | Hebbar Sudarshan Chief Medical Officer | Grant or award · Warrant | +124,486 | 124,486 | ||
| 2026-08-19 | Hebbar Sudarshan Chief Medical Officer | Grant or award · Warrant | +124,486 | 124,486 | ||
| 2026-08-19 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-08-19 | Glicklich Alan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-08-19 | Zaytsev Evgeny Director | Grant or award · Warrant | +1,450,267 | 1,450,267 | ||
| 2026-08-19 | Zaytsev Evgeny Director | Grant or award · Warrant | +1,450,267 | 1,450,267 | ||
| 2026-08-19 | Zaytsev Evgeny Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-08-19 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 1 of 29 · 565 trades